Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Item
http://www.wikidata.org/entity/Q37520997
A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls.Review article: prescribing medications in patients with cirrhosis - a practical guide.Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinion.Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation.Some considerations on the predictions of pharmacokinetic alterations in subjects with liver disease.Pharmacokinetics of antidepressants in patients with hepatic impairment.Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations.Minimal hepatic encephalopathy is associated with falls.Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis.Cognitive dysfunction in cirrhosis is associated with falls: a prospective study
P2860

Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.

Item
http://www.wikidata.org/entity/Q37520997
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetic changes of psy ...... lications for dose adaptation.
@en
Pharmacokinetic changes of psy ...... lications for dose adaptation.
@nl
type
label
Pharmacokinetic changes of psy ...... lications for dose adaptation.
@en
Pharmacokinetic changes of psy ...... lications for dose adaptation.
@nl
prefLabel
Pharmacokinetic changes of psy ...... lications for dose adaptation.
@en
Pharmacokinetic changes of psy ...... lications for dose adaptation.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P356
P1433
P1476
Pharmacokinetic changes of psy ...... lications for dose adaptation.
@en
P2093
P2860
P2888
P304
P31
P356
10.2165/00002018-200932070-00003
P433
P478
P577
P5875
P6179
P698